Summary of Hibiscus sabdariffa
Primary Information, Benefits, Effects, and Important Facts
Hibiscus Sabdariffa (Roselle) is a supplemental herb that is derived from the plant's calyces, which are the collection of sepals separating the blooming flower from the stem. The calyces have traditionally been steeped into tea where the anthocyanins (red-blue pigmentation) is steeped into the water and drank for medicinal purposes.
Although it has a variety of claims medicinally, it appears to have evidence to support its role in reducing blood pressure in persons with elevated blood pressure. It may be this through ACE inhibitory potential (although this is admittedly weak) or benefitting the endothelium via nitric oxide related mechanisms (appears to be in better accordance with the amount of anthocyanins that reach the blood). Reductions in both diastolic and systolic blood pressure have been noted, and for the most part appear to be reliable in presence although not so much in magnitude of benefit (ie. blood pressure is reliably reduced, but the degree of reduction seems to vary).
In regards to diabetes and blood glucose control, Roselle appears to have limited evidence to support these claims but the evidence is so far in support. Mechanisms are not known, and the remarkable potency in animal studies seems to be markedly less in the limited human interventions looking at it. Roselle does appear to weakly inhibit carbohydrate absorption enzymes, yet is synergistic with Morus Alba (White Mulberry) in doing so; a tea made of White Mulberries and Roselle, although currently not supported in vivo, is possibly an effective carbohydrate absorption inhibitory tea.
The interactions of Roselle and weight loss are not too clear-cut, and it seems to be highly intertwined with studies on Roselle toxicity; Roselle is known to be toxic in higher doses, and weight loss more often than not precedes chronic toxicity. For studies that note weight loss without toxicity, it seems to be related to reduced food intake in rats and mice rather than direct fat burning effects.
The appetite suppressing effects seem to be fairly reliable in rats, but caution should be taken in applying these effects to humans. Aside from not being reported as a side-effect in any human study, the bioactive known as Hibiscus Acid is similarly structured to (-)-Hydroxycitric acid from Garcinia Cambogia which is known to reduce appetite in rats reliably but not humans.
Low doses of Roselle tea or supplements appear to be effective in reducing blood pressure, and may be anti-diabetic. It is unlikely that Roselle can cause weight loss independent of a reduction of appetite
The toxicity itself seems to occur in mice and rats in a similar idea as the blood pressure reducing effects in humans, as in they occur reliably although the dose required to induce toxicity and what exactly occurs seems to vary from one study to another. This may be related to the exact molecules mediating toxicity not being known right now. For the majority of toxic effects, the lowest they have occurred is 200mg/kg in rats (2.2g dried calyx for a 150lb human). Human studies have used this dose or above with no apparent side effects though. The toxicity of these doses of Roselle need to be evaluated more.
One concern that does exist is testicular toxicity, which occurs fairly reliably at 200mg/kg or above in animals but has not been investigated in humans. Roselle appears to be anti-fertility in men, inducing abnormal sperm morphology. In females, there was a series of studies suggesting Roselle could cause abnormal (higher) birth weights in offspring with a delay of pubertal onset; for the most part these are attributed to the appetite suppressing effect causing maternal malnutrition, with no per se mechanisms harming the pup (via lactation) currently known.
Although these toxic effects can possibly be avoided by adhering to proper dosing, the amount of safety information in humans is not as expansive as would be desired; the therapeutic threshold (degree of 'safety buffer' between the active dose and toxic dose) is also lower than desirable, so possible toxic effects with overdosing Roselle is probably more relevant than other supplements.
Higher doses of Roselle do exert toxic effects, although none of these toxic effects have been reported in humans (that being said, they have not conclusively been disproven either). It would be prudent to avoid taking too much Roselle, especially since many benefits of Roselle (elaborating on in complete summary) are not dose-dependent above the lowest observable toxic dose of 2.2g/150lb human
Learn which supplements work (and which don’t) to achieve your health goals
Enter your email to get our free mini-course on supplements.
100% backed by science, we take an independent and unbiased approach to figure out what works (and what's a waste of time and money). Arm yourself with the knowledge needed to make the right choices to improve your health.
Things To Know & Note
Is a Form Of
Also Known As
Roselle, Isakpa, Krachiap daeng, Sour Tea
Goes Well With
Morus Alba in inhibiting alpha-amylase
Chrysanthemum Indicus in inhibiting alpha-amylase
Aegle marmelos in inhibiting alpha-amylase
Caution NoticeExamine.com Medical Disclaimer
Anthocyanins are heat sensitive, and if preparing Roselle tea measures should be taken to not expose the tea to excessive levels of heat and steeping. Steeping the tea does not abolish the benefits if done normally
How to Take Hibiscus sabdariffa
Recommended dosage, active amounts, other details
When using Hibiscus Sabdariffa as a tea, a dried calyx (the part of the blooming top of a flower that is not the petals, but beneath them) weighing about a gram is steeped into tea; drunk either once in the morning or twice a day with 8 hours between doses.
Supplemental Hibiscus Sabdariffa is taken according to the content of anthocyanins; 10mg of anthocyanins derived from Hibiscus Sabradiffa (which would be 1g of a 1% extract or 500mg of a 2% extract) appears to be effective.
Higher doses are associated with toxicity in rats, and it would be prudent to not exceed the above doses unnecessarily.
Human Effect Matrix
The Human Effect Matrix looks at human studies (it excludes animal and in vitro studies) to tell you what effects hibiscus sabdariffa has on your body, and how strong these effects are.
|Grade||Level of Evidence [show legend]|
|Robust research conducted with repeated double-blind clinical trials|
|Multiple studies where at least two are double-blind and placebo controlled|
|Single double-blind study or multiple cohort studies|
|Uncontrolled or observational studies only|
Level of Evidence
? The amount of high quality evidence. The more evidence, the more we can trust the results.
Magnitude of effect
? The direction and size of the supplement's impact on each outcome. Some supplements can have an increasing effect, others have a decreasing effect, and others have no effect.
Consistency of research results
? Scientific research does not always agree. HIGH or VERY HIGH means that most of the scientific research agrees.
|Notable||Very High See all 6 studies|
|Notable||Moderate See all 4 studies|
|-||Very High See 2 studies|
|-||Very High See all 3 studies|
|-||Very High See all 3 studies|
|-||Very High See all 3 studies|
|-||Very High See 2 studies|
|Minor||- See study|
|Minor||- See study|
|Minor||- See study|
|Minor||- See study|
|-||- See study|
|-||- See study|
|-||- See study|
|-||- See study|
|-||- See study|
Scientific Research on Hibiscus sabdariffa
Click on any below to expand the corresponding section. Click on to collapse it.
Hibiscus Sabdariffa (of the Malvaceae family) is the plant where its leaves and stems are commonly referred to as Hibiscus tea (whereas other species of the Hibiscus family such as Hibiscus Macranthus are not commonly used as teas) and sometimes is referred to the colloquiol name of Roselle or Sour Tea.
The calyx (flowers) of the plant are commonly used for teas, where the white calyx of Hibiscus Sabdariffa has the name 'Isakpa' by the Yorubas of southwestern Nigeria, 'Krachiap daeng' in Thailand, 'flor de Jamaica' or simply 'Jamaica' in Mexico, and Lo-Shen. It has limited traditional medicinal use, and tends to be a treatment for high blood pressure, gastrointestinal disorders, diaphoresis, and anuria. The red flowers have sometimes been used traditionally for their pigmentation as a dye, which may have a role in histological studies.
The following compounds and the quantities are listed below, and those found in the aqueous extracts are most likely found in teas made from Rosella (anthocyanins found in higher amounts in red Roselle):
(Seeds) Dihydrosterculic (1.57% of the oil, which is 17.35% total seed weight) and Vernolic acid (3.52%), uncommon dietary fatty acids
(Seeds) β-sitosterol, Daucosterol, Clerosterol, δ-5-avenasterol, and cholesterol
Although one study noted that water extracts of Roselle appear to be poor sources of phenolics overall, with the red and white variants having 2.3+/-0.8mg/100g and 1.7+/-0.2mg/g respectively and a lesser content of flavonoids (0.1-0.2mg/100g), another study noted that phenolics and flavonoids reached 58.80+/-1.34mg/g and 13.57+/-0.65mg/g respectively.
The relative amount of phenolics that are anthocyanins are relatively high, at 0.45% of dry weight of the red calyx. This is approximately half the concentration of anthocyanins found in blackberry juice, according to one study.
Anthocyanins may be subject to degradation when exposed to heat, with one study noting an activation energy of 54kJ/mol in the temperature range of 80-90°C and another noting a range of 47-61kJ/mol.
Anthocyanins may be degraded by heat treatment, although several human studies still use tea as a vessel for experimenting with Roselle (so it appears that this heat destruction may not be practically relevant)
One study with oral intake of 130.25mg Anthocyanins (65.56mg Cyanidin-3-Sambubioside and 62.12mg Delphinidin-3-Sambubioside) has failed to find appreciable serum levels following ingestion of the tea, while another study measuring the serum noted a Cmax for Delphinidin-3-Sambubioside (1.26ng/mL) and Cyanidin-3-Sambubioside (2.23ng/mL) at the Tmax of 90 minutes (both compounds) with AUC values of 2.59ng/mL/h and 4.77ng/mL/h respectively.
Urinary concentrations of Delphinidin-3-Sambubioside, Cyanidin-3-Sambubioside, or anthocyanin conjugates following oral ingestion of 130.25mg Anthocyanins via Hibiscus Sabdariffa tea (65.56mg Cyanidin-3-Sambubioside, 62.12mg Delphinidin-3-Sambubioside, 0.15mg Cyanidin-3-Glucoside, and 2.42mg Delphinidin-3-Glucoside) have been noted, and the same research group has conducted another study where 147.4mg Anthocyanins (62.6 Cyanidin-3-Sambubioside and 81.6mg Delphinidin-3-Sambubioside) was given orally to participants noted that detection of these glycosides can be found in the urine within 2 hours, with a maximum excretion rate of 7.51mcg/h; Cyanidin and Delphinidin glucosides could not be determined due to low urinary concentrations. This latter study noted that the amount of anthocyanins detected in the urine is about 0.018% of the oral dose, with studies on anthocyanins in general suggesting most of the metabolism occurs in the colon by intestinal microflora.
The anthocyanins have been tested for pharmacokinetics in humans, and they appear to be fairly rapidly excreted with poor bioavailability; the glycosides themselves (Delphinidin-3-Sambubioside rather than Delphinidin) are found in the urine, but the overall exposure to anthocyanins after oral administration is poor
Oral administration of a polyphenolic enriched Hibiscus Sabdariffa extract to rats resulted in a variety of pharmacokinetic profiles for active ingredients of this herb.
Hibiscus acid at an oral dose of 244.1umol reached a Cmax of 112.50+/-4.57uM and took over 2 hours to do so, while its conjugate (Hibiscus Acid hydroxyethylester; 125.3umol) peaked at 6.07+/-0.77uM at a similarly slow time.
N-feruloyltyramine was found to peak after 20 minutes to 0.54+/-0.16uM following oral ingestion of 1uM, and conferred a half-life of 47.8 minutes.
Some serum parameters are noted with the non-anthocyanin compounds in rats
A study giving 10g of Hibiscus Sabdariffa tea acutely noted urinary concentrations of Cyanidin-3-Sambubioside (18.7+/-11.4mcg) and Delphinidin-3-Sambubioside (6.54+/-3.41mcg) with a metabolite of the latter known as Delphinidin Monoglucuronide (3.92+/-1.60mcg) with total Anthocyanins in the urine measuring at 29.1+/-12.6mcg over 24 hours; this was following oral ingestion of 130.25mg Anthocyanins with a known Cyanidin-3-Sambubioside (65.56mg) and Delphinidin-3-Sambubioside (62.12mg) content.
Oral ingestion of 25-50mg/kg of Hibiscus Sabdariffa water extract for 28 days in rats increased the activity of Na+/K+ATPase (218-256% of baseline) and Ca2+/Mg2+ATPase (600-752%) in cardiac tissue; this may underlie the ability of Hibiscus Sabdariffa to attenuate cardiac contractility in response to adrenaline. These effects do not appear to be associated with any overt cardiac toxicity after 28 days of ingestion and do not appear to follow dose-response.
One study with rats using 50-200mg/kg of the calyx water extract for 10 weeks that noted reductions in blood pressure with all doses (not significantly different from each other, occurring at week 4) as well as a prevention of cardiac enlargement (which occurred in control). This study also noted that the surface area of cardiac capillaries (blood vessels) was increased 59-85.9% in a dose-dependent manner relative to control and the length of capillaries increased 56.9-77.6% (with the middle dose being most effective). The authors hypothesized that the reduction in cardiac size over time may be related to ACE inhibition, as this has been noted in vitro with Hibiscus Sabdariffa via competitive inhibition and this phenomena has been noted to occur with pharmaceutical ACE inhibitors.
Mechanistically speaking, a water extract of Hibiscus Sabdariffa is able to concentration dependently relax arteries precontracted by high potassium (27.9% relaxation at 1mg/mL; the EC50 relative to this being 3.37+/-0.26mcg/mL) or phenylephrine (86.01% at 1mg/mL; EC50 of 3.83+/-0.18mcg/mL); it should be noted that these are not EC50 values relative to contraction per se, but relative to maximal contraction. This relaxation was inhibited by L-NAME and Methylene Blue as well as removal of the endothelium, suggesting they are related to the Nitric Oxide system.
An ACE inhibitor potential of Roselle has been noted via competitive inhibition, which is related to the anthocyanins Delphinidin and Cyanidin as 3-Sambubioside glycosides with IC50 values of 141.61μM/84.55μg/mL (Ki of 31.9μM) and 117.75μM/68.41μg/mL (Ki 56.9μM) respectively; both of these were less effective than the active control, Lisinopril, but greater than that of other bioflavonoids such as apigenin, luteolin, and Quercetin glycosides. A basic water extract seemed to outperfom the anthocyanin rich fragment in this study (IC50 40.04μg/mL versus 91.2μg/mL) suggesting other bioactives not in the anthocyanin class are more active.
Mechanistically, the extract does possess ACE inhibitory potential via the anthocyanins although these are not as strong as pharmaceutical reference drugs.
A study where 10g dried calyx infused in 510mL water (9.6mg anthocyanins) drunk as tea daily before breakfast for 4 weeks was associated with an 11% reduction in systolic blood pressure (139.05 to 123.73mmHg) and 12.5% reduction in diastolic blood pressure (90.81 to 79.52mmHg) in persons with diagnosed hypertension not currently taking other antihypertensive agents. When compared to the active control of 50mg Captopril (taken in two divided doses) for the same period of time was not significantly different in effects. These effects are noted in both prehypertensive and hypertensive adults over 6 weeks, but with thrice daily ingestion of 240mL tea with main meals (1.25g of the calyx each serving with 7.04mg Anthocyanins) in a blinded manner (placebo tea sweetened and colored to mimick Roselle tea) noted a reduction of systolic and diastolic blood pressure by 5.5% and 4% respectively in hypertensive persons and to similar level in prehypertensive persons. Mean Arterial Pressure was reduced significantly by 4.7% when compared to baseline, but barely missed statistical significance relative to placebo (P=0.054). Although extending for 6 weeks, significant reductions in both blood pressures were noted by week 2, and other studies using Hibiscus Sabdariffa tea over 15 days have replicated these reductions in blood pressure, with measurements on day 12 reaching reductions of 11.2% systolic and 10.7% diastolic in essential hypertensive persons. This latter study had reductions in blood pressure about two-fold observed in the previous study at the 2 week interval, but this may simply be due to this demographic having higher blood pressure at the start of the study.
When compared to Lisinopril, the 12.21% blood pressure reduction observed with 250mg Anthocyanins was less than that of 10mg Lisinopril.
In type II diabetics, Roselle tea consumed over 30 days was able to reduce systolic blood pressure from 134.4+/-11.8 to 112.7+/-5.7 (16.1% reduction) when the control group drinking black tea actually had an increase (118.6+/-14.9 to 127.3+/-8.7; 7.3% increase); Roselle also decreased mean pulse pressure to 66% of baseline values.
Repeated human trials have noted a reduction in blood pressure associated with drinking moderate amounts of Roselle tea. Only one trial has attempted to blind participants to the treatment by giving them a falsely scented and flavored placebo tea, but this also replicated the benefits associated with Roselle
In hypercholesterolemic persons (220mg/dL or greater), 12 weeks of Roselle extract standardized to either 10mg (capsules) or 20mg (via tea) total Anthocyanins was able to reduce serum triglycerides and this has been replicated with 100mg of Roselle extract (19mg Anthocyanin Sambubiosides) where over 31 days in persons with metabolic syndrome triglycerides were reduced 23% relative to baseline (no control group) and HDL-C increased 10%; this latter study failed to note any reductions of LDL-C or Total cholesterol.
When making tea from the calyxes (2g steeped for 25-30 minutes and drunk; twice a day for a month), type II diabetic persons have noted increases in HDL-C (16.7%) and decreases in ApoB100 (3.4%), total cholesterol (7.6%) and LDL-C (8%). The increase in APo-A1 (4.6%) slightly missed being statistically significant.
In hypercholesterolemics with serum LDL-C in the 130-190mg/dL range who received 1g of the plant extract daily (hydroalcoholic leaf extract) for 90 days did not influence body mass nor did it significantly influence any measured parameter in serum (Total cholesterol, LDL-C, HDL-C, and blood glucose).
Improvements may occur in regards to cholesterol and lipoproteins in persons with metabolic ailments (currently hypercholesterolemia and diabetes studies in humans), although the degree of improvement is moderate relative to other compounds
In regards to triglycerides, 5-15% of the diet as Hibiscus Sabdariffa ethanolic extract for 4 weeks noted decreases in total lipids (12.3%) and triglycerides (48%), with another study using 5-10% of the calyx itself reaching 49-53% reduction of serum lipids. A mechanistic study thought that this may be related to activation of AMPK, which was noted in hepatocytes and suppressed SREBP-1 (a protein mediating hepatic fatty acid synthesis).
The absorption of triglycerides has been noted to be significantly reduced at 5% of the diet as Hibiscus Sabdariffa in rats (reducing apparent fatty acid absorption from 95.1% to 91.4%), as assessed by fecal analysis; 10-15% were associated with less fecal weight secondary to less food intake.
In human studies, one study in diabetics notes a 14.9% decrease with 2g of calyx steeped for 25-30 minutes and drunk twice a day for a month with a study in hypercholesterolemics using 1g of a hydroalcoholic extract over 90 days failing to reach statistical significance.
Studies in rats suggest potent hypolipidemic (triglyceride lowering) effects of Hibiscus Sabdariffa possible related to hepatic fatty acid synthesis suppression and possible fatty acid burning via AMPK; studies in humans using lower doses (commonly used for blood pressure health) tend to have far less potency
Roselle appears to inhibit the alpha-glucoside enzyme with more potency using Red Hibiscus (IC50 25.2ug/mL) than the White variant (47.4ug/mL) although the opposite trend exists on the alpha-amylase enzyme with the White variant being more potent (90.5ug/mL) than the red (187.9ug/mL); all four of these values were weaker than the active control of Arcabose.
In diabetic rats (streptozotocin), 100-200mg/kg Roselle daily was able to reduce the spike in fasting glucose by approximately 60-65% and the both doses significantly reduced the increase in serum insulin; 200mg/kg almost normalizing insulin relative to non-diabetic control. Similar potency has been noted elsewhere with an alloxan-induced diabetic model, where an ethanolic extract of Hibiscus Sabdariffa at 200mg/kg was associated with preventing 57% of the increase in blood glucose as well as partly attenuating the increases in lipids, cholesterol, and the artherogenic index (the latter by 32%); all of somewhat similar efficacy as 10mg/kg Lovastatin.
A human study using 100mg of Hibiscus Sabdariffa extract (19% anthocyanin sambubiosides) for one month noted reductions in blood glucose (7% reduction from baseline) which outperformed the diet condition, although pairing diet and the extract improved the blood glucose reduction to 9%.
In 3T3-LI adipocytes, an inhibition of adipocyte differentiation can be achieved at very high concentrations (500mcg/mL) with an equally weak inhibition of triglyceride uptake (IC50 799+/-225mcg/mL). This same study noted that a purified extract of Roselle for polyphenolics only improved the IC50 to 9.1+/-2.8mcg/mL, and when fractionating further these effects were thought to be due to delphinidin and cyanidin-3-sambubiosides, chlorogenic acid, tetra-O-methyljeediflavanone, and other glycosylated flavonoids.
120mg/kg of a Hibiscus extract (28% anthocyanins) to obese rats for 60 days in two daily doses of 60mg/kg noted that obese mice had body weight gain suppressed with significance at 7 weeks, with normal weight mice noting a trend towards suppressed body weight but not reaching significance. This study noted decreased food intake, which was thought to underlie the effects observed.
Hibiscus Sabdariffa anthocyanins up to 200mg/kg bodyweight in rats for 5 days has failed to significantly influence estrogen levels in serum, and have failed to alter uterine weight (indicative of estrogenic effects independent of estrogen serum concentrations).
A study dissolving 10g of Hibiscus Sabdariffa (130.5mg Anthocyanins) in 200mL water for acute consumption with a breadroll which measured serum for the next 10 hours noted increases in serum antioxidant potential (measured by FRAP) despite no changes in uric acid, although an increase in Vitamin C AUC was noted.
Serum levels of MCP-1 (Monocyte Chemoattractant Protein-1 is a biomarker of inflammation), after consumption of the calyx extract at 10g, are reduced by 17% within 90 minutes; this study attempted to measure IL-6 and IL-8 but no detectable levels were determined at any time in control or with Hibiscus.
The aqueous extracts of Roselle appear to reduce protein expression of αENaC after oral administration to adrenalectomized rats, which may be related to the diuretic and natiuretic (sodium excreting) effects of Roselle. This diuretic effect is known as potassium sparing, and works in a dose-dependent manner between doses of 1500-2500mg/kg (authors stating that, due to extraction, this equates to 5mg/kg) although the highest dose was less effective than 13mg/kg furosemide.
Appears to have diuretic properties
A study using drug-induced calcium kidney stone formation in rats treated with 250-750mg/kg Roselle extract was able to significantly reduce calcium deposition in renal tissue (no dose dependence noted, underperformed relative to 750mg/kg Cystone) as assessed by histology; the increases in phosphorus and urea (in kidney stone control) was reduced with comparable potency to Cystone, the reference drug.
In persons ingesting 1.5g of the dried calyx as tea twice a day, it appears that in persons who have not had a kidney stone previously that a trend exists towards increased uricosuria (uric acid excretion in the urine) while in those who have formed a kidney stone this relationship is statistically significant; the effect was noted to be transient, and vanished during a washout period.
May possess kidney stone reducing properties
When fed to rats at an oral dose of 25-50mg/kg (aqueous extract) over 28 days was able to reduce the activity of Ca2+/Mg2+ATPase (no apparent dose response), without influencing NA2+/K+ATPase (although a trend to increase); plasma albumin or ALP was noted, but a decrease of urea and creatinine were noted at the higher dose of 50mg/kg.
In rats given a 5/6 Nephrectomy and then divided into either control or a group treated with Roselle (250mg/kg of a water extract from red calyxes for 6 weeks after a 1 week downtime after surgery) noted significantly reduced glomerular and tubulointerstitial injuries (histological examination) and less fibrosis with no significant effect on albuminuria or serum IL-6/TNF-α levels. The increase in blood pressure associated with 5/6 Nephrectomies was significantly attenuated.
Blood pressure related mechanisms have been noted in renal tissue, which may be related to those observed in human trials
The non-anthocyanin portions also have hepatoprotective effects, as evidence by a pigment free extract (with a high concentration of green tea catechins including EGCG at 20%) able to protect from acetominophen induced hepatotoxicity.
A study in persons with metabolic syndrome noted that 31 days of 100mg Roselle extract (19mg Anthocyanin Sambubiosides) was able to reduce serum ALT and AST, suggesting Roselle attenuates hepatic damage.
One study investigating rat testes noted that four weeks of 200mg/kg Hibiscus extract in male mice (a dose similar to those used in other studies) was able to adversely affect sperm morphology. The percentage of abnormal sperm morphology (nonspecific morphology abnormalities) increased from 18.5% at baseline to 43.5-52.5%; sertoli cells also appeared to be altered. Another study over the course of 5 days failed to find any abnormalities with the testes beyond a slight decrease in testicular protein content with 100mg/kg (none at 200mg/kg) and a third notes that large doses between 1.6-4.2g/kg of the water extract did not alter testicular body weight ratio, with the two higher doses reducing sperm count and altering sperm and tubular morphology.
Although a possible estrogenic effects is though to exist, a failure to alter testicle weight was noted at doses even up to 4.2g/kg bodyweight for 12 weeks and a reduction of the testicular:body weight ratio tends to be indicative of estrogen-related testicular toxicity. Currently the mechanism mediating possible testicular toxicity are unknown, with the authors of the aforementioned rat study citing the following and hypothesizing Quercetin may be related, as Quercetin isolated from Roselle coloring was noted to possess mutagenic activities in vitro.
There appears to be some possible testicular toxic effects, seen at the dose of 200mg/kg (human dose of about 2g for a 150lb person) or above. The mechanisms underlying this possible toxicity are not known, and no studies exist in humans assessing testicular toxicity
Morus Alba (White Mulberry) is a herb where the leaves and stems are commonly drunk as tea for anti-diabetic purposes, and this manner of consumption is known to isolate alpha-glucoside enzyme inhibitors and possibly prevent the absorption of carbohydrates. The potency on the alpha-amylase enzyme (that mediates starch digestion) from Morus Alba is relatively weak with 2mg/mL inhibiting 1.17+/-0.74% of the enzyme's action. Roselle can inhibit the enzyme by 18.99+/-1.39% at this concentration, but adding both together synergistically increases inhibition to 65.75+/-0.60%.
Chrysanthemum Indicus and Roselle appear to be synergistic in inhibiting the alpha-amylase enzyme in vitro.
One human study using Roselle tea prepared twice a day for 15 days in persons with hypertension specifically investigating renal toxicity failed to find any evidence of toxicity relative to either baseline or control (black tea).
Looking at rats, a dose-escalation study noted that no mortality existed for acute dosing up until 2,010mg/kg, where 2,020mg/kg was associated with one death and 2,050mg/kg killed all five rats given the dose; the authors suggested that 2g/kg was approximately the maximum tolerated dose, although a 90 day trial using this dose noted some mortality associated with diarhhea on day 8 with water and ethanolic extracts, with those given a 50:50 extract lasting to day 28; 300mg/kg was not associated with as much death, with sporadic toxic effects on RBCs, increased AST, and food intake with 120mg/kg over 60 days not exerting any overt toxic effects.
Despite the aforementioned, a review of safety has noted that the LD50 to be above 5,000mg/kg citing a rat intervention in hypertensive rats. The LD50 may be variable due to processing techniques and varying levels of bioactives, as the bioactive(s) underlying this toxicity is currently not known.
2,000mg may be approximately the lowest toxicity threshold, with no acute but possible chronic adverse effects at this dose and higher doses being more likely to induce toxic effects
Due to the potential toxicity, 200mg/kg as a rat dose (32mg/kg human dose, 2.2g of calyx per day for a 150lb person) may be a practical upper limit for usage
Testicular Toxicity falls into this category somewhat (in this particular case, sperm cells are implicated) and discussed in the section of 'Interactions with Organs', subset 'Testicles'
In a study on mice using 0.6g/100mL or 1.8g/100mL of Hibiscus Sabdariffa extract in the drinking water during 21 days of lactation reported suppressed food and water intake in mothers (no dose dependence on the former) and both increased body weight and delayed onset of puberty in rat pups. This study itself attributed a reduced food intake during lactation to these effects, and a followup study by the same researchers noted a dose-dependent increase in serum sodium and corticosterone, and was again attributed to maternal malnutrition. These results have been replicated twice again by the same research group, with one noting that these trials have not noted birth defects per se.
One trial has noted that the offspring consuming the same doses of Hibiscus Sabdariffa themselves had delayed pubertal onset, again attributed to reduced food and water intake.
A series of studies that note increased rat pup weight with a possible delay in puberty, which have been linked to maternal malnutrition (no pair fed studies as of yet, which are studies that restrict nutrition in one group to match that of the drug group; attempting to delineate effects of caloric deprivation and effects of the drug. Due to the lack of pair fed studies, this hypothesis is still tentative)
- Sčančar J, et al. Ni speciation in tea infusions by monolithic chromatography-ICP-MS and Q-TOF-MS. Anal Bioanal Chem. (2012)
- Ademiluyi AO, Oboh G. Aqueous Extracts of Roselle (Hibiscus sabdariffa Linn.) Varieties Inhibit α-Amylase and α-Glucosidase Activities In Vitro. J Med Food. (2012)
- Haji Faraji M, Haji Tarkhani A. The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. J Ethnopharmacol. (1999)
- Seujange Y, et al. Hibiscus Sabdariffa Linnaeus Aqueous Extracts Attenuate the Progression of Renal Injury in 5/6 Nephrectomy Rats. Ren Fail. (2012)
- Herrera-Arellano A, et al. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. Phytomedicine. (2004)
- Olatunji LA, et al. Effects of aqueous extract of Hibiscus sabdariffa on renal Na(+)-K(+)-ATPase and Ca(2+)-Mg(2+)-ATPase activities in Wistar rats. Zhong Xi Yi Jie He Xue Bao. (2012)
- Lans CA. Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus. J Ethnobiol Ethnomed. (2006)
- Bassey RB, et al. Factors influencing extract of Hibiscus sabdariffa staining of rat testes. Biotech Histochem. (2012)
- Orisakwe OE, Husaini DC, Afonne OJ. Testicular effects of sub-chronic administration of Hibiscus sabdariffa calyx aqueous extract in rats. Reprod Toxicol. (2004)
- Ali BH, Al Wabel N, Blunden G. Phytochemical, pharmacological and toxicological aspects of Hibiscus sabdariffa L.: a review. Phytother Res. (2005)
- Peng CH, et al. Hibiscus sabdariffa polyphenolic extract inhibits hyperglycemia, hyperlipidemia, and glycation-oxidative stress while improving insulin resistance. J Agric Food Chem. (2011)
- Beltrán-Debón R, et al. The aqueous extract of Hibiscus sabdariffa calices modulates the production of monocyte chemoattractant protein-1 in humans. Phytomedicine. (2010)
- Fernández-Arroyo S, et al. Bioavailability study of a polyphenol-enriched extract from Hibiscus sabdariffa in rats and associated antioxidant status. Mol Nutr Food Res. (2012)
- Jiménez-Ferrer E, et al. Diuretic Effect of Compounds from Hibiscus sabdariffa by Modulation of the Aldosterone Activity. Planta Med. (2012)
- Frank T, et al. Consumption of Hibiscus sabdariffa L. aqueous extract and its impact on systemic antioxidant potential in healthy subjects. J Sci Food Agric. (2012)
- Saeed IA, et al. Estrogenic activities of ten medicinal herbs from the middle East. J Chromatogr Sci. (2013)
- Herranz-López M, et al. Synergism of plant-derived polyphenols in adipogenesis: perspectives and implications. Phytomedicine. (2012)
- Wang ML, et al. Assessment of oil content and fatty acid composition variability in two economically important Hibiscus species. J Agric Food Chem. (2012)
- Mohamed R, et al. Roselle (Hibiscus sabdariffa) seed oil is a rich source of gamma-tocopherol. J Food Sci. (2007)
- Cisse M, et al. Thermal degradation kinetics of anthocyanins from blood orange, blackberry, and roselle using the arrhenius, eyring, and ball models. J Agric Food Chem. (2009)
- Mourtzinos I, et al. Thermal stability of anthocyanin extract of Hibiscus sabdariffa L. in the presence of beta-cyclodextrin. J Agric Food Chem. (2008)
- Frank T, et al. Pharmacokinetics of anthocyanidin-3-glycosides following consumption of Hibiscus sabdariffa L. extract. J Clin Pharmacol. (2005)
- Rechner AR, et al. The metabolism of dietary polyphenols and the relevance to circulating levels of conjugated metabolites. Free Radic Res. (2002)
- Fakeye TO, et al. Effects of water extract of Hibiscus sabdariffa, Linn (Malvaceae) 'Roselle' on excretion of a diclofenac formulation. Phytother Res. (2007)
- Fakeye TO, Pal A, Khanuja SP. Anxiolytic and sedative effects of extracts of Hibiscus sabdariffa Linn (family Malvaceae). Afr J Med Med Sci. (2008)
- Chronic Administration of Aqueous Extract of Hibiscus sabdariffa Enhances Na+K+-ATPase and Ca2+Mg2+-ATPase Activities of Rat Heart.
- Mechanism of relaxant effectmediated by an aqueous extract of Hibiscus sabdariffa petals in isolated rats aorta.
- Inuwa I, et al. Long-term ingestion of Hibiscus sabdariffa calyx extract enhances myocardial capillarization in the spontaneously hypertensive rat. Exp Biol Med (Maywood). (2012)
- Zhang R, Crump J, Reisin E. Regression of left ventricular hypertrophy is a key goal of hypertension management. Curr Hypertens Rep. (2003)
- Ziada AM, et al. Long-term exercise training and angiotensin-converting enzyme inhibition differentially enhance myocardial capillarization in the spontaneously hypertensive rat. J Hypertens. (2005)
- Ajay M, et al. Mechanisms of the anti-hypertensive effect of Hibiscus sabdariffa L. calyces. J Ethnopharmacol. (2007)
- Ojeda D, et al. Inhibition of angiotensin convertin enzyme (ACE) activity by the anthocyanins delphinidin- and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa. J Ethnopharmacol. (2010)
- McKay DL, et al. Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr. (2010)
- Herrera-Arellano A, et al. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. Planta Med. (2007)
- Mozaffari-Khosravi H, et al. The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes. J Hum Hypertens. (2009)
- Hernández-Pérez F, Herrera-Arellano A. Therapeutic use Hibiscus sabadariffa extract in the treatment of hypercholesterolemia. A randomized clinical trial. Rev Med Inst Mex Seguro Soc. (2011)
- Gurrola-Díaz CM, et al. Effects of Hibiscus sabdariffa extract powder and preventive treatment (diet) on the lipid profiles of patients with metabolic syndrome (MeSy). Phytomedicine. (2010)
- Mozaffari-Khosravi H, et al. Effects of sour tea (Hibiscus sabdariffa) on lipid profile and lipoproteins in patients with type II diabetes. J Altern Complement Med. (2009)
- Kuriyan R, et al. An evaluation of the hypolipidemic effect of an extract of Hibiscus Sabdariffa leaves in hyperlipidemic Indians: a double blind, placebo controlled trial. BMC Complement Altern Med. (2010)
- Carvajal-Zarrabal O, et al. The consumption of Hibiscus sabdariffa dried calyx ethanolic extract reduced lipid profile in rats. Plant Foods Hum Nutr. (2005)
- el-Saadany SS, et al. Biochemical dynamics and hypocholesterolemic action of Hibiscus sabdariffa (Karkade). Nahrung. (1991)
- Yang MY, et al. The hypolipidemic effect of Hibiscus sabdariffa polyphenols via inhibiting lipogenesis and promoting hepatic lipid clearance. J Agric Food Chem. (2010)
- Carvajal-Zarrabal O, et al. Effect of Hibiscus sabdariffa L. dried calyx ethanol extract on fat absorption-excretion, and body weight implication in rats. J Biomed Biotechnol. (2009)
- Farombi EO, Ige OO. Hypolipidemic and antioxidant effects of ethanolic extract from dried calyx of Hibiscus sabdariffa in alloxan-induced diabetic rats. Fundam Clin Pharmacol. (2007)
- Alarcon-Aguilar FJ, et al. Effect of Hibiscus sabdariffa on obesity in MSG mice. J Ethnopharmacol. (2007)
- Ali BH, et al. Effect of Hibiscus sabdariffa and its anthocyanins on some reproductive aspects in rats. Nat Prod Commun. (2012)
- Alarcón-Alonso J, et al. Pharmacological characterization of the diuretic effect of Hibiscus sabdariffa Linn (Malvaceae) extract. J Ethnopharmacol. (2012)
- Laikangbam R, Damayanti Devi M. Inhibition of calcium oxalate crystal deposition on kidneys of urolithiatic rats by Hibiscus sabdariffa L. extract. Urol Res. (2012)
- Prasongwatana V, et al. Uricosuric effect of Roselle (Hibiscus sabdariffa) in normal and renal-stone former subjects. J Ethnopharmacol. (2008)
- Lee CH, et al. A polyphenol extract of Hibiscus sabdariffa L. ameliorates acetaminophen-induced hepatic steatosis by attenuating the mitochondrial dysfunction in vivo and in vitro. Biosci Biotechnol Biochem. (2012)
- Mahmoud YI. Effect of extract of Hibiscus on the ultrastructure of the testis in adult mice. Acta Histochem. (2012)
- Identification of mutagenic substances in Roselle Color, Elderberry Color and Safflower Yellow.
- Adisakwattana S, et al. In vitro inhibitory effects of plant-based foods and their combinations on intestinal α-glucosidase and pancreatic α-amylase. BMC Complement Altern Med. (2012)
- Mohagheghi A, et al. The effect of hibiscus sabdariffa on lipid profile, creatinine, and serum electrolytes: a randomized clinical trial. ISRN Gastroenterol. (2011)
- Fakeye TO, et al. Toxic effects of oral administration of extracts of dried calyx of Hibiscus sabdariffa Linn. (Malvaceae). Phytother Res. (2009)
- Onyenekwe PC, et al. Antihypertensive effect of roselle (Hibiscus sabdariffa) calyx infusion in spontaneously hypertensive rats and a comparison of its toxicity with that in Wistar rats. Cell Biochem Funct. (1999)
- Iyare EE, Adegoke OA. Maternal consumption of an aqueous extract of Hibiscus sabdariffa during lactation accelerates postnatal weight and delays onset of puberty in female offspring. Niger J Physiol Sci. (2008)
- Iyare EE, Adegoke OA. Mechanism of the delayed puberty onset in offspring of rats that consumed aqueous extract of Hibiscus sabdariffa during pregnancy. Niger J Physiol Sci. (2008)
- Body mass index at onset of puberty in rats exposed to aqueous extract of Hibiscus sabdariffa in utero.
- Gestational Outcome in Rats That Consumed Aqueous Extract of Hibiscus sabdariffa During Pregnancy.
- Iyare EE, Nwagha UI. Delayed puberty onset in rats that consumed aqueous extract of Hibiscus sabdariffa during the juvenile-pubertal period. Pak J Biol Sci. (2009)